1. Home
  2. YSXT vs LSTA Comparison

YSXT vs LSTA Comparison

Compare YSXT & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo YSX Tech. Co. Ltd Class A Ordinary Shares

YSXT

YSX Tech. Co. Ltd Class A Ordinary Shares

N/A

Current Price

$1.01

Market Cap

27.7M

ML Signal

N/A

Logo Lisata Therapeutics Inc.

LSTA

Lisata Therapeutics Inc.

N/A

Current Price

$1.74

Market Cap

28.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
YSXT
LSTA
Founded
2011
1980
Country
China
United States
Employees
N/A
N/A
Industry
Automotive Aftermarket
Misc Health and Biotechnology Services
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.7M
28.9M
IPO Year
2023
2000

Fundamental Metrics

Financial Performance
Metric
YSXT
LSTA
Price
$1.01
$1.74
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$15.00
AVG Volume (30 Days)
49.9K
465.4K
Earning Date
02-03-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
20.42
EPS
N/A
N/A
Revenue
N/A
$35,283,868.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$5.57
N/A
Revenue Growth
N/A
56.90
52 Week Low
$0.50
$0.99
52 Week High
$5.01
$5.07

Technical Indicators

Market Signals
Indicator
YSXT
LSTA
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
YSXT
LSTA

About YSXT YSX Tech. Co. Ltd Class A Ordinary Shares

YSX Tech Co Ltd provide business solutions to enterprise customers, mainly insurance companies and brokerages, in China. The company has three operating segments: Auto Insurance Aftermarket Value-added Services, Other Scenario-based Customized Services, and Software Development and Information Technology Services. Key revenue is generated from the Auto Insurance Aftermarket Value-added Services segment, which includes four types of value-added services: vehicle safety inspection and check services, vehicle driving risk screening services, designated driver and rescue services, and vehicle maintenance and other value-added services.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.

Share on Social Networks: